The importance of endothelium-derived mediators to the efficacy of dual anti-platelet therapy

Expert Rev Hematol. 2016 Mar;9(3):223-5. doi: 10.1586/17474086.2016.1140035.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Aspirin / pharmacology
  • Aspirin / therapeutic use*
  • Blood Platelets / drug effects*
  • Blood Platelets / metabolism
  • Blood Platelets / pathology
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / metabolism
  • Endothelium, Vascular / pathology
  • Humans
  • Platelet Aggregation Inhibitors / pharmacology
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Purinergic P2Y Receptor Antagonists / pharmacology
  • Purinergic P2Y Receptor Antagonists / therapeutic use*
  • Thrombosis / metabolism
  • Thrombosis / pathology
  • Thrombosis / prevention & control*

Substances

  • Platelet Aggregation Inhibitors
  • Purinergic P2Y Receptor Antagonists
  • Aspirin